LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "macroglobulinemia" as a keyword



Photo by emileseguin from unsplash

Disseminated cutaneous immunoglobulin M macroglobulinosis associated with cryoglobulinemia and minimal residual disease of Waldenström macroglobulinemia

Sign Up to like & get
recommendations! Published in 2019 at "JAAD Case Reports"

DOI: 10.1016/j.jdcr.2019.06.037

Abstract: The dermatologic manifestations of Waldenstrom macroglobulinemia (WM) are typically categorized as disease specific or non–disease specific.1 Non–disease-specific findings are related to hyperviscosity or cryoglobulinemia, including mucosal bleeding, purpura, livedo reticularis, and Raynaud phenomenon. Two rare types… read more here.

Keywords: disseminated cutaneous; minimal residual; cryoglobulinemia; disease ... See more keywords
Photo by impulsq from unsplash

Diagnosis of Waldenström macroglobulinemia

Sign Up to like & get
recommendations! Published in 2019 at "Baylor University Medical Center Proceedings"

DOI: 10.1080/08998280.2019.1596681

Abstract: Abstract Waldenström macroglobulinemia is a rare disorder affecting about 1400 people annually in the United States. This case report reviews from a primary care provider’s perspective the initial presentation of a patient who complained of… read more here.

Keywords: waldenstr macroglobulinemia; diagnosis waldenstr; hematology; macroglobulinemia ... See more keywords
Photo from wikipedia

Current options to manage Waldenström’s macroglobulinemia

Sign Up to like & get
recommendations! Published in 2017 at "Expert Review of Hematology"

DOI: 10.1080/17474086.2017.1339596

Abstract: ABSTRACT Introduction: Waldenström’s macroglobulinemia (WM) is a rare, incurable B-cell lymphoma, with a median survival of 5–10 years in symptomatic patients. There is no consensus on the standard of care and several agents are currently… read more here.

Keywords: current options; waldenstr macroglobulinemia; manage waldenstr; macroglobulinemia ... See more keywords
Photo by bermixstudio from unsplash

Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients.

Sign Up to like & get
recommendations! Published in 2018 at "Blood"

DOI: 10.1182/blood-2018-07-863241

Abstract: TO THE EDITOR: Waldenstrom macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma associated with immunoglobulin M monoclonal gammopathy.[1][1] The majority of patients carry the L265P mutation in MYD88,[2][2] whereas 40% of patients carry mutations in CXCR4.[3][3]… read more here.

Keywords: impact cxcr4; negative impact; macroglobulinemia; waldenstrom macroglobulinemia ... See more keywords
Photo by nci from unsplash

Predictors of disease progression in smoldering Waldenström macroglobulinemia.

Sign Up to like & get
recommendations! Published in 2018 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2018.36.15_suppl.7571

Abstract: 7571Background: There are limited data on predictors of disease progression in patients (pts) with smoldering Waldenstrom Macroglobulinemia (SWM). We aim to address this issue in a large cohort of ... read more here.

Keywords: predictors disease; progression smoldering; smoldering waldenstr; macroglobulinemia ... See more keywords
Photo by xteemu from unsplash

Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia

Sign Up to like & get
recommendations! Published in 2020 at "Caspian Journal of Internal Medicine"

DOI: 10.22088/cjim.11.3.340

Abstract: Background: Waldenstrom macroglobulinemia is a lymphoplasmacytic lymphoma with elevated serum immunoglobulin M and multi-organ involvement. Primary systemic amyloidosis usually develops due to immunoglobulin light chains depositions in different organs due to an underlying gammopathy. Case… read more here.

Keywords: presentation; macroglobulinemia; waldenstrom macroglobulinemia; cutaneous amyloidosis ... See more keywords
Photo from wikipedia

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect

Sign Up to like & get
recommendations! Published in 2018 at "Haematologica"

DOI: 10.3324/haematol.2017.184176

Abstract: Irrespective of age, patients with aggressive Waldenstrom macroglobulinemia (WM) who have exhausted chemo-immunotherapy-based approaches may be candidates for allogeneic hematopoietic cell transplantation (HCT), a strategy that has been rarely attempted.[1][1]–[7][2] In Seattle, conditioning with read more here.

Keywords: hematopoietic cell; cell transplantation; allogeneic hematopoietic; macroglobulinemia ... See more keywords